Institutional investors purchased a net $792.4 thousand shares of THOR during the quarter ended March 2015 and now own 97.17% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 590.7 Thousand shares of Thoratec Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 303.5 Thousand shares of Thoratec Corp
QUANTITATIVE SYSTEMATIC STRATEGI... Bought 45.8 Thousand shares of Thoratec Corp